Trump Says ACA ‘Will Destroy Health Care In America,’ Promises Special Session To Repeal It
The Republican candidate gave a speech on the first day of open enrollment capitalizing on the recent news of spiking premiums.
Los Angeles Times:
Trump Warns That Obamacare Will 'Destroy American Healthcare Forever,' But Offers Few Details On How He'd Change It
Campaigning in the battleground state of Pennsylvania, Donald Trump and his running mate, Mike Pence, launched a new round of attacks on the Affordable Care Act on Tuesday. “Obamacare has to be replaced, and we will do it very quickly,” Trump told supporters outside Philadelphia, promising a rare special session of Congress if he is elected. “If we don’t repeal and replace, we will destroy American healthcare forever.” (Levey, 11/1)
The Washington Post:
The Future Of Health Care, According To Clinton Or Trump
Many Americans’ health care — and the roiling health-care debate in Washington — is likely to be very different depending on whether Democrat Hillary Clinton or Republican Donald Trump becomes the next president. We looked at what both have said they would do with major aspects of the health-care system. (Goldstein, 11/1)
In other national health care news —
The Wall Street Journal:
Health Law Enrollment Opens Amid Volatility
The fourth open enrollment for health coverage under the Affordable Care Act opened Tuesday, a critical 90 days that the Obama administration hopes will boost participation and stabilize markets roiled by premium increases and insurer withdrawals. HealthCare.gov and state equivalents began taking applications Tuesday morning from people signing up for individual health coverage and learning about their eligibility for subsidies. (Armour and Radnofsky, 11/1)
The Wall Street Journal:
Why It Pays To Shop Around For That MRI
Consumers may drive across town to save a few bucks on a gallon of gas or $1 on a gallon of milk, but when it comes to health care, those same buyers aren’t as price-conscious. That is a problem for companies as health costs continue to rise, and it’s increasingly a problem for workers, too, as high-deductible health plans force employees to spend more out of pocket. (Silverman, 11/1)
Bloomberg:
Investors Are Hooked On Flipping Pharmaceuticals
Dealmakers have always flipped companies. Lately, they’ve been flipping something else: aging pharmaceuticals. Take Actimmune, developed by Genentech Inc. decades ago. By 2012, sales were fizzling. Then rights to the immune-disorder treatment were acquired by a company backed by private equity. The price climbed, 434 percent in two years, and Actimmune was a hot property. Horizon Pharma Plc snapped it up. Or consider the old Novartis AG cold-sore cream Denavir, notching a 372 percent gain as it changed hands twice with private equity help. Or Dutoprol, 1,057 percent more expensive after a flip. Or Miacalcin, 3,259 percent higher. (Langreth, 11/2)